Diabetes Reversal Leader Virta Health Raises $133M Series E To Take Type 2 Diabetes Reversal Mainstream

Apr 19, 2021•about 4 years ago

Amount Raised

$133 Million

Round Type

series e

San Francisco

Description

Virta Health, the leader in type 2 diabetes reversal, today announced $133 million of equity financing led by Tiger Global. The latest funding round will accelerate Virta's efforts to drive widespread adoption of its telehealth-powered diabetes reversal treatment. Virta helps people reverse their chronic disease while removing the need for costly medications, including insulin.

Company Information

Company

Virta Health

Location

San Francisco, California, United States

About

Virta Health helps people reverse type 2 diabetes and other chronic conditions. Current approaches manage disease progression through increased medication use and infrequent doctor visits. Virta reverses type 2 diabetes through innovations in technology, nutrition science, and continuous remote care from physicians and behavioral experts. In clinical studies, 94% of patients reduce or eliminate insulin use, and weight-loss exceeds FDA benchmarks by 150%. Virta works with the largest health plans, employers, and government organizations and puts 100% of its fees at risk based on clinical and financial outcomes. To learn more about how Virta is transforming lives by reversing type 2 diabetes and other chronic diseases, visit www.virtahealth.com or follow us on Twitter and LinkedIn.

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Diabetes Reversal Leader Virta Health Raises $133M Series E To Take Type 2 Diabetes Reversal Mainstream

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Funding Insights

Company Information